Joaquín
Casal Rubio
Hospital Universitario de Jaén
Jaén, EspañaPublications in collaboration with researchers from Hospital Universitario de Jaén (3)
2022
2021
2014
-
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166